[1]Galar A, Yuste JR, Espinosa M, et al. Clinical and economic impact of rapid reporting of bacterial identification and antimicrobial susceptibility results of the most frequently processed specimen types[J]. Eur J Clin Microbiol Infect Dis, 2012, 31(9): 2445-2452.
[2]Nguyen-Hieu T. Microbial sampling process can change results of microbiological analysis in periodontitis diagnosis. A minireview[J]. J Investig Clin Dent, 2013, 4(3): 151-159.
[3]Salluh JI, Soares M. ICU severity of illness scores: APACHE, SAPS and MPM[J]. Curr Opin Crit Care, 2014, 20(5): 557-565.
[4]Wang N, Neilan AM, Klompas M. Staphylococcus intermedius infections: case report and literature review[J]. Infect Dis Rep, 2013, 5(1): e3.
[5]Vandenesch F, Célard M, Arpin D, et al. Catheter-related bacteremia associated with coagulase-positive Staphylococcus intermedius[J]. J Clin Microbiol, 1995, 33(9): 2508-2510.
[6]Boerlin P, Eugster S, Gaschen F, et al. Transmission of opportunistic pathogens in a veterinary teaching hospital[J]. Vet Microbiol, 2001, 82(4): 347-359.
[7]陈佰义, 何礼贤, 胡必杰, 等. 中国鲍曼不动杆菌感染诊治与防控专家共识[J]. 中国医药科学, 2012, 2(8): 3-8.
[8]李小宁, 李娟, 姚永红. 鲍曼不动杆菌的耐药性及产ESBL和碳青霉烯酶分析[J]. 中国临床药理学与治疗学, 2012, 17(1): 30-33.
[9]胡付品, 朱德妹, 汪复, 等. 2013年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2014, 14(5): 369-378.
[10]喻华, 刘华, 黄文芳, 等. 四川省细菌耐药监测网2012年细菌耐药性监测[J]. 中国抗生素杂志, 2014, 39(5): 332-337.
[11]宋秀杰, 路聪哲, 方庭正,等. 老年支气管扩张合并急性感染的病原菌及其耐药性研究[J]. 中国临床药理学与治疗学, 2012, 17(8): 914-918.
[12]汪红, 胡龙华, 宁长秀,等. 耐碳青霉烯类抗生素鲍曼不动杆菌耐药机制的研究[J]. 中国临床药理学与治疗学, 2014, 17(12): 1093-1098.
[13]杨会志, 荚恒敏, 张莉莉. 2012年我院临床分离病原菌及耐药性监测分析[J]. 中国临床药理学与治疗学, 2012, 19(10): 1338-1342.
[14]Sato N, Suzuki H, Hayashi H, et al. New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents[J]. Jpn J Antibiot, 2008, 61(5): 314-338.
[15]叶有娣, 谢家政. 多重耐药鲍曼不动杆菌治疗药物研究进展[J]. 中国临床药理学与治疗学, 2016, 21(1): 116-120.
[16]Fishbain J, Peleg AY. Treatment of Acinetobacter infections[J]. Clin Infect Dis, 2010, 51(1): 79-84.
[17]Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baurnannii infections:epidemiology and management[J]. Curr Opin Infect Dis, 2010, 23(4): 332-339. |